|
시장보고서
상품코드
2077255
체외 폐 모델 시장 : 종류별, 용도별, 최종사용자별, 지역별Global In Vitro Lung Model Market, By Type, By Application, By End User, By Geography |
||||||
세계의 체외 폐 모델 시장은 2026년에 3억 8,750만 달러 규모가 될 것으로 추정되며, 2033년에 10억 580만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 14.6%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 3억 8,750만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026-2033년까지 예측 기간의 CAGR: | 14.60% | 2033년 시장 규모 예측: | 10억 580만 달러 |
체외 폐 모델은 인간의 폐가 지닌 생리학적 및 해부학적 특성을 재현하는 것을 목적으로 하는 실험 시스템입니다. 이것들은 신약 개발, 독성 검사, 폐 질환 연구 분야에서 널리 활용되고 있습니다. 체외에서 배양된 인간 폐세포 및 조직을 활용함으로써, 이러한 모델들은 동물 실험을 대체할 수 있는, 비교적 비용 대비 효과가 높고 효과적인 대안을 제시하고 있습니다. 또한, 동물 모델과 비교하여 인간의 폐 생물학 및 질환의 병태를 연구하기 위해 보다 현실적이고 제어하기 쉬운 환경을 제시하고 있습니다. 앞으로 조직 공학, 미세유체 공학 및 기타 기술의 발전에 힘입어, 생체 내 폐 미세환경을 더욱 충실하게 재현할 수 있는 고도로 복잡한 3D 폐 모델의 개발이 진전될 것으로 기대됩니다.
시장 역학
전 세계 체외 폐 모델 시장은 제약 기업의 의약품 연구개발 투자 증가, 동물 실험에 대한 엄격한 규제, 호흡기질환 유병률 상승 등의 요인에 힘입어 성장하고 있습니다. 그러나 고해상도 3D 폐 모델 개발에 따른 높은 비용과 조직의 짧은 보존 기간이 시장 성장을 저해할 것으로 예상됩니다. 한편, 미세 가공 기술과 3D 바이오프린팅 기술의 지속적인 발전으로 인해, 제조사들이 차세대 생체 모방 모델을 개발하는 데 있어 큰 기회가 생길 것으로 예상됩니다. 또한, 개별 환자로부터 유래한 세포나 조직을 활용한 맞춤형 폐 모델 개발에 대한 관심이 높아지고 있는 점도 시장 성장에 기여할 것으로 전망됩니다.
한편, 시장 참여자들의 연구 개발이 활발해짐에 따라 예측 기간 동안 시장 성장이 더욱 가속화될 것으로 전망됩니다. 예를 들어, 2025년 3월 6일, 생명공학 기업인 AlveoliX AG는 동료 심사를 거친 오픈 액세스 과학 저널인 Frontiers Media S.A.에 "호흡하는 '폐 온 칩'에서 in situ와 유사한 에어로졸 전달을 모델링하는 다중 흡입 플랫폼"이라는 제목의 연구 논문을 발표했습니다. 이 조사는 천식, 만성 폐쇄성 폐질환(COPD), 섬유증 등 다양한 호흡기질환을 대상으로 한 것입니다. 이러한 중증 폐 질환에 대해 미국 식품의약국(FDA)이 승인한 흡입제 수가 제한적이기 때문에 전임상 연구에서 흡입 입자의 독성을 보다 정확하게 예측하기 위해 체내 검사에서 인간과 관련성이 높은 대체 체외 모델로의 전환이 진행되고 있습니다.
본 조사의 주요 특징:
- 이 조사는 다양한 부문에 걸친 잠재적 수익 기회를 밝혀내고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공하고 있습니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 체외 폐 모델 시장의 주요 기업 개요을 발표하고 있습니다.
- 이 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 관해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 본 '세계 체외 폐 모델 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 체외 폐 모델 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 체외 폐 모델 시장 : 유형별, 2021-2033년
제5장 세계의 체외 폐 모델 시장 : 용도별, 2021-2033년
제6장 세계의 체외 폐 모델 시장 : 최종사용자별, 2021-2033년
제7장 세계의 체외 폐 모델 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.07.10Global In Vitro Lung Model Market is estimated to be valued at USD 387.5 Mn in 2026 and is expected to reach USD 1,005.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 14.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 387.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 14.60% | 2033 Value Projection: | USD 1,005.8 Mn |
In vitro lung models are experimental systems that aim to mimic the physiological and anatomical properties of the human lungs. They are widely used in drug discovery, toxicity testing, and studying lung diseases. By utilizing human lung cells and tissues grown outside of the body, these models offer a relatively affordable and effective alternative to animal testing. They also provide a more realistic and controllable environment to study human lung biology and disease pathology compared to animal models. Going forward, advances in tissue engineering, microfluidics, and other technologies are expected to help develop highly complex 3D lung models that can better recreate the in vivo lung microenvironment.
Market Dynamics:
The global in vitro lung model market is driven by factors such as rising drug R&D investments by pharmaceutical companies, stringent regulations regarding animal testing, and increasing prevalence of respiratory diseases. However, high costs associated with developing advanced 3D lung models and shorter shelf life of tissues are expected to restrain the market growth. Meanwhile, ongoing advances in microfabrication and 3D bioprinting technologies are projected to create significant opportunities for manufacturers to develop next-gen biomimetic models. The market is also anticipated to gain from growing focus on developing personalized lung models incorporating individual patient-derived cells and tissues.
On the other hand, rising research and development by market players is further expected to propel the market growth over the forecast period. For instance, on March 6, 2025, AlveoliX AG, a biotechnology company, published a study in Frontiers Media S.A., a peer-reviewed, open access, scientific journals, entitled "A multiplex inhalation platform to model in situ like aerosol delivery in a breathing lung-on-chip" for various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD) and fibrosis, due to limited number of U.S. Food and Drug Administration, approved inhaled drugs for these serious lung conditions has led to a shift from in vivo towards the use of alternative in vitro human-relevant models to better predict the toxicity of inhaled particles in preclinical research.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global In vitro lung model market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Histogen Inc., OliX Pharmaceuticals, Cipla Limited, Aclaris Therapeutics, Inc., Merck & Co., Inc., Daiichi-Sankyo Co., Ltd., Johnson and Johnson Services, Inc., Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, PureTech, Vitabiotics, Dr. Reddy's Laboratories, HCell Inc., Follica, Inc. and Ranbaxy Laboratories Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global In vitro lung model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global In vitro lung model market
Detailed Segmentation:
- Global In Vitro Lung Model Market, By Type (Revenue, USD Mn, 2021 - 2033)
- 2D Model
- 3D Model
- Global In Vitro Lung Model Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Drug Discovery & Toxicology Studies
- Physiological Research
- 3D Model Development
- Others
- Global In Vitro Lung Model Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Academic and Research Institutes
- Biopharmaceutical Companies
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Global In Vitro Lung Model Market, Key Players
- Epithelix
- MATTEK
- Lonza
- Emulate
- AlveoliX AG
- Nortis
- CN Bio Innovations Ltd
- MIMETAS
- InSphero
- ATTC Global
- Tissuse GmbH
- Cn Bio Innovations Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global In Vitro Lung Model Market, By Type
- Global In Vitro Lung Model Market, By Application
- Global In Vitro Lung Model Market, By End User
- Global In Vitro Lung Model Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rising prevalence of lung diseases
- High costs associated with animal models
- Growing preference for 3D lung models over 2D models
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Service offering Portfolio
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global In Vitro Lung Model Market, By Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- 2D Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- 3D Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
5. Global In Vitro Lung Model Market, By Application, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Drug Discovery & Toxicology Studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Physiological Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- 3D Model Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
6. Global In Vitro Lung Model Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
7. Global In Vitro Lung Model Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 -2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Epithelix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MATTEK
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lonza
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Emulate
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AlveoliX AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Nortis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Strategies
- CN Bio Innovations Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- MIMETAS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- InSphero
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- ATTC Global
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Tissuse GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cn Bio Innovations Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
